|
|
|
Insider
Information: |
Neal James R |
Relationship: |
Director |
City: |
Berkeley |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
72,149 |
|
Indirect Shares
|
21,560 |
|
|
Direct
Value |
$305,431 |
|
|
Indirect Value
|
$549,780 |
|
|
Total
Shares |
93,709 |
|
|
Total
Value |
$855,211 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
4
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
2.0
|
-4.0
|
Percentage
Gain/Loss : |
132.9%
|
-127.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
XOMA Corporation |
XOMA |
|
2022-07-15 |
11,822 |
2022-07-15 |
21,560 |
Premium* |
|
Monterey Bio Acquisition Corp |
MTRY |
Director |
2021-09-30 |
35,000 |
|
0 |
Premium* |
|
Processa Pharmaceuticals, Inc. |
PCSA |
|
2023-06-27 |
14,407 |
2023-06-27 |
0 |
Premium* |
|
Palisade Bio Inc |
PALI |
Director |
2024-02-09 |
10,920 |
2024-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XOMA |
XOMA Corporation |
CEO |
|
2020-12-15 |
4 |
A |
$25.00 |
$200,000 |
I/I |
8,000 |
8,000 |
0 |
- |
|
XOMA |
XOMA Corporation |
CEO |
|
2020-12-15 |
4 |
AS |
$41.15 |
$1,074,998 |
D/D |
(26,000) |
20,849 |
0 |
% |
|
XOMA |
XOMA Corporation |
CEO |
|
2020-12-15 |
4 |
OE |
$5.50 |
$143,000 |
D/D |
26,000 |
46,849 |
0 |
- |
|
XOMA |
XOMA Corporation |
CEO |
|
2021-04-09 |
4 |
A |
$25.00 |
$200,000 |
I/I |
8,000 |
8,000 |
0 |
- |
|
XOMA |
XOMA Corporation |
CEO |
|
2021-06-25 |
4 |
S |
$33.36 |
$303,474 |
D/D |
(9,027) |
11,822 |
0 |
% |
|
MTRY |
Monterey Bio Acquisition ... |
Director |
|
2021-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,000 |
|
- |
|
XOMA |
XOMA Corporation |
CEO |
|
2022-03-21 |
4 |
OE |
$4.03 |
$201,500 |
D/D |
50,000 |
61,822 |
0 |
- |
|
XOMA |
XOMA Corporation |
CEO |
|
2022-03-21 |
4 |
S |
$29.01 |
$1,450,250 |
D/D |
(50,000) |
11,822 |
0 |
% |
|
XOMA |
XOMA Corporation |
CEO |
|
2022-03-22 |
4 |
S |
$30.02 |
$70,209 |
D/D |
(2,339) |
11,822 |
0 |
% |
|
XOMA |
XOMA Corporation |
CEO |
|
2022-03-22 |
4 |
OE |
$4.03 |
$9,426 |
D/D |
2,339 |
14,161 |
0 |
- |
|
XOMA |
XOMA Corporation |
CEO |
|
2022-03-23 |
4 |
OE |
$4.03 |
$4,477 |
D/D |
1,111 |
12,933 |
0 |
- |
|
XOMA |
XOMA Corporation |
CEO |
|
2022-03-23 |
4 |
S |
$30.02 |
$33,348 |
D/D |
(1,111) |
11,822 |
0 |
% |
|
XOMA |
XOMA Corporation |
CEO |
|
2022-07-15 |
4 |
OE |
$4.03 |
$100,750 |
D/D |
25,000 |
36,822 |
0 |
- |
|
XOMA |
XOMA Corporation |
CEO |
|
2022-07-15 |
4 |
AS |
$29.55 |
$746,104 |
D/D |
(25,000) |
11,822 |
0 |
% |
|
PCSA |
Processa Pharmaceuticals,... |
|
|
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,407 |
14,407 |
0 |
- |
|
PALI |
Palisade Bio Inc |
Director |
|
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,920 |
10,920 |
0 |
- |
|
66 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|